Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Yore

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|March 17, 2007
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J miceKaren Liby, Darlene B Royce, Charlotte R Williams, et al.
Cell Metabolism|September 25, 2018
Methodological Issues in Studying PAHSA Biology: Masking PAHSA EffectsIsmail Syed, Jennifer Lee, Odile D Peroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268Karen Liby, Renee Risingsong, Darlene B Royce, et al.
Molecular Cancer Therapeutics|May 17, 2008
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesisKaren Liby, Candice C Black, Darlene B Royce, et al.
Cancer Research|June 3, 2005
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signalingKaren Liby, Thomas Hock, Mark M Yore, et al.
Molecular and Cellular Biology|March 21, 2012
Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanismJulie Norseen, Tetsuya Hosooka, Ann Hammarstedt, et al.
Cell|October 11, 2014
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effectsMark M Yore, Ismail Syed, Pedro M Moraes-Vieira, et al.
Cancer Research|February 21, 2006
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazoleMelinda S Yates, Mi-Kyoung Kwak, Patricia A Egner, et al.
Cell Metabolism|February 8, 2018
Palmitic Acid Hydroxystearic Acids Activate GPR40, Which Is Involved in Their Beneficial Effects on Glucose HomeostasisIsmail Syed, Jennifer Lee, Pedro M Moraes-Vieira, et al.
Cancer Research|August 15, 2008
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxinKaren Liby, Mark M Yore, Bill D Roebuck, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|March 17, 2007
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J miceKaren Liby, Darlene B Royce, Charlotte R Williams, et al.
Cell Metabolism|September 25, 2018
Methodological Issues in Studying PAHSA Biology: Masking PAHSA EffectsIsmail Syed, Jennifer Lee, Odile D Peroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268Karen Liby, Renee Risingsong, Darlene B Royce, et al.
Molecular Cancer Therapeutics|May 17, 2008
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesisKaren Liby, Candice C Black, Darlene B Royce, et al.
Cancer Research|June 3, 2005
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signalingKaren Liby, Thomas Hock, Mark M Yore, et al.
Molecular and Cellular Biology|March 21, 2012
Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanismJulie Norseen, Tetsuya Hosooka, Ann Hammarstedt, et al.
Cell|October 11, 2014
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effectsMark M Yore, Ismail Syed, Pedro M Moraes-Vieira, et al.
Cancer Research|February 21, 2006
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazoleMelinda S Yates, Mi-Kyoung Kwak, Patricia A Egner, et al.
Cell Metabolism|February 8, 2018
Palmitic Acid Hydroxystearic Acids Activate GPR40, Which Is Involved in Their Beneficial Effects on Glucose HomeostasisIsmail Syed, Jennifer Lee, Pedro M Moraes-Vieira, et al.
Cancer Research|August 15, 2008
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxinKaren Liby, Mark M Yore, Bill D Roebuck, et al.
Pageof 2